Physician profile
David Aaron Cohen
NPI 1114361573
$85,261.88
in general payments reported to CMS, 2019-2025
12 companies · $25K in 2025
The $25K reported for 2025 was more than what 97% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.54 · 2022: $38.52 · 2023: $180 · 2024: $60K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $76K · Travel and Lodging: $8,320 · Food and Beverage: $1,243 · Education: $8.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,579.00 |
| Travel and Lodging | $8,319.65 |
| Food and Beverage | $1,242.92 |
| Education | $8.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $84,693.97 | 2024-2025 | |
| Merz North America, INC. | $153.23 | 2023 | Xeomin |
| Organogenesis INC. | $137.43 | 2025 | Affinity |
| Leo Pharma INC. | $62.15 | 2025 | Anzupgo, Adbry |
| E.R. Squibb & Sons, L.L.C. | $59.13 | 2019 | |
| Abbvie INC. | $57.12 | 2025 | |
| Glaxosmithkline, LLC. | $19.31 | 2022 | |
| Foundation Medicine, INC. | $19.21 | 2022 | |
| Organon LLC | $19.01 | 2025 | Vtama |
| Bayer Healthcare Pharmaceuticals INC. | $14.41 | 2019 | |
| Dermavant Sciences, INC. | $14.10 | 2023 | Vtama |
| Sun Pharmaceutical Industries INC. | $12.81 | 2023 | Blu-U, Odomzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.